BRPI0908638A2 - agente para indução/manuntenção de remissão; método para manutenção da remissão induzida e uso de um agonista - Google Patents

agente para indução/manuntenção de remissão; método para manutenção da remissão induzida e uso de um agonista

Info

Publication number
BRPI0908638A2
BRPI0908638A2 BRPI0908638A BRPI0908638A BRPI0908638A2 BR PI0908638 A2 BRPI0908638 A2 BR PI0908638A2 BR PI0908638 A BRPI0908638 A BR PI0908638A BR PI0908638 A BRPI0908638 A BR PI0908638A BR PI0908638 A2 BRPI0908638 A2 BR PI0908638A2
Authority
BR
Brazil
Prior art keywords
maintenance
remission
agonist
induced
induction
Prior art date
Application number
BRPI0908638A
Other languages
English (en)
Inventor
Kazuhiko Kuriyama
Tokutarou Yasue
Tomoyuki Kago
Original Assignee
Kyorin Seiyaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Seiyaku Kk filed Critical Kyorin Seiyaku Kk
Publication of BRPI0908638A2 publication Critical patent/BRPI0908638A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1793—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
BRPI0908638A 2008-05-20 2009-05-19 agente para indução/manuntenção de remissão; método para manutenção da remissão induzida e uso de um agonista BRPI0908638A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2008131634 2008-05-20
PCT/JP2009/059176 WO2009142195A1 (ja) 2008-05-20 2009-05-19 寛解導入維持剤

Publications (1)

Publication Number Publication Date
BRPI0908638A2 true BRPI0908638A2 (pt) 2015-10-06

Family

ID=41340128

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0908638A BRPI0908638A2 (pt) 2008-05-20 2009-05-19 agente para indução/manuntenção de remissão; método para manutenção da remissão induzida e uso de um agonista

Country Status (19)

Country Link
US (1) US20110152275A1 (pt)
EP (1) EP2305305A4 (pt)
JP (1) JPWO2009142195A1 (pt)
KR (1) KR20110010638A (pt)
CN (1) CN102123735A (pt)
AU (1) AU2009250509A1 (pt)
BR (1) BRPI0908638A2 (pt)
CA (1) CA2724592A1 (pt)
CO (1) CO6280501A2 (pt)
IL (1) IL209441A0 (pt)
MA (1) MA32593B1 (pt)
MX (1) MX2010012676A (pt)
MY (1) MY154685A (pt)
NZ (1) NZ589412A (pt)
RU (1) RU2505288C2 (pt)
SG (1) SG191598A1 (pt)
TW (1) TW201000109A (pt)
WO (1) WO2009142195A1 (pt)
ZA (1) ZA201008340B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200946105A (en) 2008-02-07 2009-11-16 Kyorin Seiyaku Kk Therapeutic agent or preventive agent for inflammatory bowel disease containing amino alcohol derivative as active ingredient

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4152884B2 (ja) * 2001-09-27 2008-09-17 杏林製薬株式会社 ジアリールエーテル誘導体とその付加塩及び免疫抑制剤
MXPA04002679A (es) * 2001-09-27 2004-07-30 Kyorin Seiyaku Kk Derivados de sulfuro de diarilo, sales de los mismos y agentes inmunosupresores que utilizan los mismos.
CA2498944C (en) 2002-09-19 2011-05-17 Yasushi Kohno Amino alcohol derivatives, salts thereof and immunosuppressive agents
KR20080103117A (ko) * 2002-09-24 2008-11-26 노파르티스 아게 탈수초성 장애의 치료에 있어서의 스핑고신-1-포스페이트 수용체 아고니스트
KR101005171B1 (ko) * 2003-02-18 2011-01-04 교린 세이야꾸 가부시키 가이샤 아미노포스폰산 유도체와 그 부가염 및 ｓ1ｐ 수용체조절제
WO2005044780A1 (ja) * 2003-11-10 2005-05-19 Kyorin Pharmaceutical Co., Ltd. アミノカルボン酸誘導体とその付加塩及びｓ１ｐ受容体調節剤
PL1772145T3 (pl) * 2004-07-16 2011-08-31 Kyorin Seiyaku Kk Sposób skutecznego stosowania leku i sposób dotyczący zapobiegania efektom ubocznym
WO2006041015A1 (ja) * 2004-10-12 2006-04-20 Kyorin Pharmaceutical Co., Ltd. アミノアルコール誘導体とその付加塩及び免疫抑制剤
JP2008521827A (ja) * 2004-11-29 2008-06-26 ノバルティス アクチエンゲゼルシャフト Ｓ１ｐ受容体アゴニストの投与レジメン
KR101476591B1 (ko) * 2005-09-09 2014-12-24 노파르티스 아게 자가면역성 질환의 치료
PT1932522E (pt) * 2005-10-07 2012-06-26 Kyorin Seiyaku Kk Agente terapêutico para doenças do fígado contendo, como princípio activo, um derivado de 2- amino-1,3-propanodiol
JP2007169194A (ja) * 2005-12-21 2007-07-05 Kyorin Pharmaceut Co Ltd ジオキサフォスフォリナン誘導体とその付加塩及びスフィンゴシン−１−リン酸（ｓ１ｐ１，ｓ１ｐ４）受容体作動薬
TWI389683B (zh) * 2006-02-06 2013-03-21 Kyorin Seiyaku Kk A therapeutic agent for an inflammatory bowel disease or an inflammatory bowel disease treatment using a 2-amino-1,3-propanediol derivative as an active ingredient
NZ574011A (en) * 2006-08-08 2011-10-28 Kyorin Seiyaku Kk Aminophosphoric acid ester derivative and s1p receptor modulator containing the same as active ingredient
MY146775A (en) * 2006-08-08 2012-09-28 Kyorin Seiyaku Kk Amino alcohol derivative and immunosuppressive agent having same as an active ingredient
AU2007334436A1 (en) * 2006-12-15 2008-06-26 Abbott Laboratories Novel oxadiazole compounds
JP5198293B2 (ja) * 2007-02-13 2013-05-15 杏林製薬株式会社 アミノアルコール誘導体を有効成分とする脱髄性疾患の治療剤又は予防剤
JP2008231027A (ja) * 2007-03-20 2008-10-02 Kyorin Pharmaceut Co Ltd アミノアルコール誘導体及びそれらを有効成分とする免疫抑制剤
JP2008239546A (ja) * 2007-03-27 2008-10-09 Kyorin Pharmaceut Co Ltd アミノアルコール誘導体及びそれらを有効成分とする免疫抑制剤

Also Published As

Publication number Publication date
MX2010012676A (es) 2011-05-10
KR20110010638A (ko) 2011-02-01
AU2009250509A8 (en) 2011-05-12
WO2009142195A1 (ja) 2009-11-26
MY154685A (en) 2015-07-15
NZ589412A (en) 2012-11-30
SG191598A1 (en) 2013-07-31
US20110152275A1 (en) 2011-06-23
JPWO2009142195A1 (ja) 2011-09-29
RU2010147292A (ru) 2012-06-27
ZA201008340B (en) 2011-08-31
IL209441A0 (en) 2011-01-31
CN102123735A (zh) 2011-07-13
EP2305305A1 (en) 2011-04-06
MA32593B1 (fr) 2011-09-01
EP2305305A4 (en) 2013-02-13
AU2009250509A1 (en) 2009-11-26
TW201000109A (en) 2010-01-01
CA2724592A1 (en) 2009-11-26
RU2505288C2 (ru) 2014-01-27
CO6280501A2 (es) 2011-05-20

Similar Documents

Publication Publication Date Title
BRPI0822972A2 (pt) "método e aparelho para redução de atrito"
BRPI0823032A2 (pt) Método e sistema para gerenciar potência em um sistema de elevador
BRPI0917910A2 (pt) método para detectar amostra de aspereza e aparelho para o método
BRPI0911587A2 (pt) sistema e método para distribuição de som dinâmico
BRPI0822345A2 (pt) Método e aparelho para mascarar perda de sinal
BRPI0923566A2 (pt) método e sistema para detecção de uma expressão vocal relevante
BRPI0918347A2 (pt) método para identificar peças utilizadas na construção e manutenção de um poço de petróleo ou gás e aparelhagem para identificar peças utilizadas na construção e manutenção de um poço de petróleo ou gás
BR112013008949A2 (pt) "aparelho e método para detecção de falha e determinação de localização"
FI20080095A0 (fi) Menetelmä ja järjestelmä testitapausten muodostamiseksi
BRPI0915499A2 (pt) métodos e sistemas para reduzir papr de um sinal ofdm
BRPI0924004A2 (pt) método e sistema para controlar o uso de um dispositivo eletrônico
BRPI0913739A2 (pt) Composição líquida, método, e, uso de composição
BRPI1008617A2 (pt) método e aparelho para lipoaspiração
BRPI0912426A2 (pt) método executado por computador, computador, e sistema para uso com poço
BRPI0913469A2 (pt) método para a realização de um ensaio de aglomerado, aparelho para a realização de um ensaio de aglomerado, uso de um método e uso de um aparelho
BRPI0905983A2 (pt) Método e aparelho para calcinação de gesso pressurizado
BRPI0910102A2 (pt) métodos e aparelho para balanceamento dinâmico de carga com e-aich
BR112013033502A2 (pt) método de cimentação em uma formação subterrânea, e, composição de cimento para uso em um poço de óleo ou gás
BRPI0914120A2 (pt) método e aparelho para determinação estrutural
BRPI0920918A2 (pt) método e aparelho aprimorados para quebrar uma emulsão
BRPI0910660A2 (pt) linguagem de expressão de senha para pesquisa imediata e publicidade
FI20090135A (fi) Välineet ja menetelmä hissikuilun mittaamiseksi
BRPI0909459A2 (pt) sistema e método para recompletação de um poço antigo
BRPI0910398A2 (pt) método e aparelho para eliminar o efeito de perfuração em medições de indução de pulso
BRPI0905943A2 (pt) "método de detectar defeitos com o uso de correntes de redemoinho e aparelho para detectar defeitos com o uso de correntes de redemoinho"

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.